These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38950869)
1. Ion channel dysregulation and cellular adaptations to alpha-synuclein in stressful pacemakers of the parkinsonian brainstem. Chiu WH; Wattad N; Goldberg JA Pharmacol Ther; 2024 Aug; 260():108683. PubMed ID: 38950869 [TBL] [Abstract][Full Text] [Related]
3. Enhanced firing of locus coeruleus neurons and SK channel dysfunction are conserved in distinct models of prodromal Parkinson's disease. Matschke LA; Komadowski MA; Stöhr A; Lee B; Henrich MT; Griesbach M; Rinné S; Geibl FF; Chiu WH; Koprich JB; Brotchie JM; Kiper AK; Dolga AM; Oertel WH; Decher N Sci Rep; 2022 Feb; 12(1):3180. PubMed ID: 35210472 [TBL] [Abstract][Full Text] [Related]
4. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease. Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457 [TBL] [Abstract][Full Text] [Related]
5. Determinants of dopaminergic neuron loss in Parkinson's disease. Surmeier DJ FEBS J; 2018 Oct; 285(19):3657-3668. PubMed ID: 30028088 [TBL] [Abstract][Full Text] [Related]
6. The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies. Seidel K; Mahlke J; Siswanto S; Krüger R; Heinsen H; Auburger G; Bouzrou M; Grinberg LT; Wicht H; Korf HW; den Dunnen W; Rüb U Brain Pathol; 2015 Mar; 25(2):121-35. PubMed ID: 24995389 [TBL] [Abstract][Full Text] [Related]
7. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model. Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026 [TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336 [TBL] [Abstract][Full Text] [Related]
9. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Van Den Berge N; Ferreira N; Gram H; Mikkelsen TW; Alstrup AKO; Casadei N; Tsung-Pin P; Riess O; Nyengaard JR; Tamgüney G; Jensen PH; Borghammer P Acta Neuropathol; 2019 Oct; 138(4):535-550. PubMed ID: 31254094 [TBL] [Abstract][Full Text] [Related]
10. Increased Expression of Alpha-, Beta-, and Gamma-Synucleins in Brainstem Regions of a Non-Human Primate Model of Parkinson's Disease. Duperrier S; Bortolozzi A; Sgambato V Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955716 [TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge. Miraglia F; Betti L; Palego L; Giannaccini G Cent Nerv Syst Agents Med Chem; 2015; 15(2):109-16. PubMed ID: 25896035 [TBL] [Abstract][Full Text] [Related]
12. GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson's disease. Ikuno M; Yamakado H; Akiyama H; Parajuli LK; Taguchi K; Hara J; Uemura N; Hatanaka Y; Higaki K; Ohno K; Tanaka M; Koike M; Hirabayashi Y; Takahashi R Hum Mol Genet; 2019 Jun; 28(11):1894-1904. PubMed ID: 30689867 [TBL] [Abstract][Full Text] [Related]
14. LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease. Alegre-Abarrategui J; Ansorge O; Esiri M; Wade-Martins R Neuropathol Appl Neurobiol; 2008 Jun; 34(3):272-83. PubMed ID: 17971075 [TBL] [Abstract][Full Text] [Related]
15. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner. Taguchi K; Watanabe Y; Tsujimura A; Tanaka M Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073 [TBL] [Abstract][Full Text] [Related]
16. Intragastric proteasome inhibition induces alpha-synuclein-immunopositive aggregations in neurons in the dorsal motor nucleus of the vagus in rats. Miwa H; Kubo T; Suzuki A; Kondo T Neurosci Lett; 2006 Jun; 401(1-2):146-9. PubMed ID: 16600504 [TBL] [Abstract][Full Text] [Related]
17. Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease. Ferrer I; Martinez A; Blanco R; Dalfó E; Carmona M J Neural Transm (Vienna); 2011 May; 118(5):821-39. PubMed ID: 20862500 [TBL] [Abstract][Full Text] [Related]
18. Targeting alpha-synuclein via the immune system in Parkinson's disease: Current vaccine therapies. Fleming SM; Davis A; Simons E Neuropharmacology; 2022 Jan; 202():108870. PubMed ID: 34742741 [TBL] [Abstract][Full Text] [Related]